Is zoledronate a safe and effective treatment option in chronic nonbacterial osteomyelitis?
An Pediatr (Engl Ed)
.
2023 Feb;98(2):142-145.
doi: 10.1016/j.anpede.2022.09.011.
Epub 2023 Jan 23.
Authors
Elisa González Vázquez
1
,
Laura Martín Pedraz
2
,
Rocío Galindo Zavala
2
,
Gisela Díaz-Cordovés Rego
2
,
Esmeralda Núñez Cuadros
2
Affiliations
1
Sección de Reumatología Infantil, UGC Pediatría, Hospital Regional Universitario de Málaga, Málaga, Spain. Electronic address: elisaglezvazquez@gmail.com.
2
Sección de Reumatología Infantil, UGC Pediatría, Hospital Regional Universitario de Málaga, Málaga, Spain.
PMID:
36697334
DOI:
10.1016/j.anpede.2022.09.011
No abstract available
Publication types
Case Reports
MeSH terms
Humans
Osteomyelitis* / drug therapy
Treatment Outcome
Zoledronic Acid / therapeutic use
Substances
Zoledronic Acid
Supplementary concepts
Chronic recurrent multifocal osteomyelitis